Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

July 1965

Volume 130 Antiviral Substances

Pages 4–482

  1. SECTION I. DETECTION AND EVALUATION OF POTENTIAL ANTIVIRAL DRUGS

    1. Top of page
    2. SECTION I. DETECTION AND EVALUATION OF POTENTIAL ANTIVIRAL DRUGS
    3. SECTION II. THIOSEMICARBAZONES
    4. SECTION III. NUCLEOSIDES
    5. SECTION IV. AGENTS USEFUL IN THE STUDY OF MECHANISMS OF VIRAL REPLICATION
    6. SECTION V. ANTNIRAL AGENTS: PAST, PRESENT, AND FUTURE
    7. SECTION VI. AGENTS USEFUL IN THE STUDY OF PATHOGENESIS OF VIRAL DISEASES
    8. SECTION VII. NEWER ANTNIRAL AGENTS
    1. INTRODUCTORY REMARKS (page 4)

      Ernest C. Herrmann Jr.

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12532.x

    2. SEARCHING FOR ANTIVIRAL MATERIALS FROM MICROBIAL FERMENTATIONS (pages 5–16)

      John Ehrlich, Bernard J. Sloan, Francis A. Miller and H. E. Machamer

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12533.x

    3. EXPERIENCE GAINED IN SCREENING FOR SYNTHETIC ANTIVIRAL COMPOUNDS (pages 17–23)

      D. A. Buthala

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12534.x

    4. EXPERIENCES IN DEVELOPING POTENTIAL ANTIVIRAL COMPOUNDS (pages 24–30)

      J. R. Dice, W. A. Rightsel, F. M. Schabel Jr. and I. W. McLean Jr.

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12535.x

    5. PROBLEMS OF IN VITRO AND IN VIVO TESTING OF ANTIVIRAL SUBSTANCES (pages 31–43)

      F. Link, B. Rada and D. Blaškovič

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12536.x

    6. EVALUATION OF ANTIVIRAL DRUGS: THE EFFECT OF AMANTADINE ON INFLUENZA IN VOLUNTEERS (pages 44–51)

      E. D. Stanley, R. E. Muldoon, L. W. Akers and G. G. Jackson

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12537.x

    7. OBSERVATIONS ON ANTIVIRAL SCREENING (pages 52–55)

      Irving S. Johnson

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12538.x

    8. UTILITY OF LEUKEMOGENIC VIRUSES FOR TESTING ANTIVIRAL AGENTS IN VIVO (pages 56–64)

      M. A. Chirigos

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12539.x

    9. DISCUSSION (pages 65–70)

      E. C. Herrmann Jr.

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12540.x

  2. SECTION II. THIOSEMICARBAZONES

    1. Top of page
    2. SECTION I. DETECTION AND EVALUATION OF POTENTIAL ANTIVIRAL DRUGS
    3. SECTION II. THIOSEMICARBAZONES
    4. SECTION III. NUCLEOSIDES
    5. SECTION IV. AGENTS USEFUL IN THE STUDY OF MECHANISMS OF VIRAL REPLICATION
    6. SECTION V. ANTNIRAL AGENTS: PAST, PRESENT, AND FUTURE
    7. SECTION VI. AGENTS USEFUL IN THE STUDY OF PATHOGENESIS OF VIRAL DISEASES
    8. SECTION VII. NEWER ANTNIRAL AGENTS
    1. BIOCHEMICAL STUDIES ON THE ANTIVIRAL ACTIVITIES OF THE ISATIN-β-THIOSEMICARBAZONES (pages 80–91)

      W. E. Magee and M. K. Bach

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12542.x

    2. THE EFFECT OF THIOSEMICARBAZONES ON THE GROWTH OF RABBIT POX VIRUS IN TISSUE CULTURE (pages 92–104)

      G. Appleyard, V. B. M. Hume and J. C. N. Westwood

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12543.x

    3. MONOCYCLIC THIOSEMICARBAZONES AS ANTIVIRAL AGENTS (pages 105–109)

      D. J. Bauer

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12544.x

    4. THE LABORATORY AND CLINICAL ASSESSMENT OF AN ISOTHIAZOLE THIOSEMICARBAZONE (M & B 7714) AGAINST POX VIRUSES (pages 118–127)

      A. R. Rao, J. A. McFadzean and S. Squires

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12546.x

    5. DISCUSSION (pages 128–134)

      R. L. Thompson

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12547.x

  3. SECTION III. NUCLEOSIDES

    1. Top of page
    2. SECTION I. DETECTION AND EVALUATION OF POTENTIAL ANTIVIRAL DRUGS
    3. SECTION II. THIOSEMICARBAZONES
    4. SECTION III. NUCLEOSIDES
    5. SECTION IV. AGENTS USEFUL IN THE STUDY OF MECHANISMS OF VIRAL REPLICATION
    6. SECTION V. ANTNIRAL AGENTS: PAST, PRESENT, AND FUTURE
    7. SECTION VI. AGENTS USEFUL IN THE STUDY OF PATHOGENESIS OF VIRAL DISEASES
    8. SECTION VII. NEWER ANTNIRAL AGENTS
    1. CELLULAR AND ANTIVIRAL EFFECTS OF HALOGENATED DEOXYRIBONUCLEOSIDES (pages 135–150)

      W. H. Prusoff, Y. S. Bakhle and L. Sekely

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12548.x

    2. HERPES KERATITIS IN RABBITS: PATHOGENESIS AND EFFECT OF ANTIVIRAL NUCLEOSIDES (pages 151–167)

      Gerald E. Underwood, George A. Elliott and Darwin A. Buthala

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12549.x

    3. IN VIVO STUDIES WITH ANTIVIRAL AGENTS (pages 168–180)

      Herbert E. Kaufman

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12550.x

    4. THE EPIDEMIOLOGY AND CHEMOTHERAPY OF HERPES SIMPLEX KERATITIS AND HERPES SIMPLEX SKIN INFECTIONS (pages 209–212)

      Jerome A. Gold, Richard C. Stewart and James McKee

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12553.x

    5. INHIBITION BY HALOGENATED DEOXYRIBONUCLEOSIDES OF THE PRODUCTION OF TUMORS BY A POLYOMA VIRUS (pages 213–216)

      D. S. Fischer, F. L. Black, E. P. Cassidy and A. D. Welch

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12554.x

    6. DISCUSSION (pages 217–225)

      E. Wecker

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12555.x

  4. SECTION IV. AGENTS USEFUL IN THE STUDY OF MECHANISMS OF VIRAL REPLICATION

    1. Top of page
    2. SECTION I. DETECTION AND EVALUATION OF POTENTIAL ANTIVIRAL DRUGS
    3. SECTION II. THIOSEMICARBAZONES
    4. SECTION III. NUCLEOSIDES
    5. SECTION IV. AGENTS USEFUL IN THE STUDY OF MECHANISMS OF VIRAL REPLICATION
    6. SECTION V. ANTNIRAL AGENTS: PAST, PRESENT, AND FUTURE
    7. SECTION VI. AGENTS USEFUL IN THE STUDY OF PATHOGENESIS OF VIRAL DISEASES
    8. SECTION VII. NEWER ANTNIRAL AGENTS
    1. INCORPORATION OF 5-BROMODEOXYURIDINE AND 5-IODODEOXYURIDINE INTO VIRAL DNA AND ITS EFFECT ON THE INFECTIVE PROCESS (pages 226–239)

      Albert S. Kaplan, Tamar Ben-Porat and Tomoya Kamiya

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12556.x

    2. THE USE OF METABOLIC INHIBITORS IN STUDIES ON THE MODE OF REPLICATION OF VACCINIA VIRUS (pages 240–248)

      N. P. Salzman, A. J. Shatkin and E. D. Sebring

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12557.x

    3. INDIRECT INHIBITION OF PROTEIN SYNTHESIS (pages 249–258)

      G. J. Dixon, W. A. Rightsel and H. E. Skipper

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12558.x

    4. COMPARATIVE STUDIES WITH SELECTIVE INHIBITORS OF PICORNAVIRUS REPRODUCTION (pages 267–281)

      H. J. Eggers, N. Ikegami and I. Tamm

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12560.x

    5. FURTHER STUDIES ON THE EFFECT OF p-FLUOROPHENYLALANINE AND PUROMYCIN ON POLIO VIRUS REPLICATION (pages 282–290)

      M. D. Scharff, D. F. Summers and L. Levintow

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12561.x

    6. MECHANISM OF CELL DAMAGE IN POLIO VIRUS INFECTION (pages 310–311)

      Igor Tamm, Rostom Bablanian and Hans J. Eggers

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12563.x

    7. DISCUSSION (pages 312–316)

      H. Eagle

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12564.x

  5. SECTION V. ANTNIRAL AGENTS: PAST, PRESENT, AND FUTURE

    1. Top of page
    2. SECTION I. DETECTION AND EVALUATION OF POTENTIAL ANTIVIRAL DRUGS
    3. SECTION II. THIOSEMICARBAZONES
    4. SECTION III. NUCLEOSIDES
    5. SECTION IV. AGENTS USEFUL IN THE STUDY OF MECHANISMS OF VIRAL REPLICATION
    6. SECTION V. ANTNIRAL AGENTS: PAST, PRESENT, AND FUTURE
    7. SECTION VI. AGENTS USEFUL IN THE STUDY OF PATHOGENESIS OF VIRAL DISEASES
    8. SECTION VII. NEWER ANTNIRAL AGENTS
    1. PANEL DISCUSSION (pages 317–318)

      R. L. Thompson

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12565.x

  6. SECTION VI. AGENTS USEFUL IN THE STUDY OF PATHOGENESIS OF VIRAL DISEASES

    1. Top of page
    2. SECTION I. DETECTION AND EVALUATION OF POTENTIAL ANTIVIRAL DRUGS
    3. SECTION II. THIOSEMICARBAZONES
    4. SECTION III. NUCLEOSIDES
    5. SECTION IV. AGENTS USEFUL IN THE STUDY OF MECHANISMS OF VIRAL REPLICATION
    6. SECTION V. ANTNIRAL AGENTS: PAST, PRESENT, AND FUTURE
    7. SECTION VI. AGENTS USEFUL IN THE STUDY OF PATHOGENESIS OF VIRAL DISEASES
    8. SECTION VII. NEWER ANTNIRAL AGENTS
    1. PANEL DISCUSSION (pages 318–329)

      E. C. Herrmann Jr.

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12566.x

    2. DEVELOPMENT OF RESISTANCE TO ANTIVIRAL DRUGS (pages 343–354)

      H. E. Renis and D. A. Buthala

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12568.x

    3. IN VIVO AND IN VITRO INHIBITION OF HEPATITIS VIRUSES BY STREPTOTHRICIN (pages 355–364)

      R. L. Stone, D. C. DeLong, R. N. Hull and I. S. Johnson

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12569.x

    4. EFFECTS OF NATURAL AND SYNTHETIC SULFATED POLYSACCHARIDES ON VIRUSES AND CELLS (pages 365–373)

      K. K. Takemoto and S. S. Spicer

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12570.x

    5. ANTIVIRAL ACTIVITY OF PAOLINS FROM CLAMS (pages 374–382)

      C. P. Li, B. Prescott, B. Eddy, G. Caldes, W. R. Green, E. C. Martino and A. M. Young

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12571.x

    6. THE EFFECT OF POLYANIONS AND POLYCATIONS ON MENGO VIRUS - L CELL INTERACTION (pages 383–389)

      John S. Colter and James B. Campbell

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12572.x

    7. KELP EXTRACTS AS ANTIVIRAL SUBSTANCES (pages 390–397)

      Ralph H. Kathan

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12573.x

    8. DISCUSSION (pages 409–411)

      F. M. Schabel Jr.

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12576.x

  7. SECTION VII. NEWER ANTNIRAL AGENTS

    1. Top of page
    2. SECTION I. DETECTION AND EVALUATION OF POTENTIAL ANTIVIRAL DRUGS
    3. SECTION II. THIOSEMICARBAZONES
    4. SECTION III. NUCLEOSIDES
    5. SECTION IV. AGENTS USEFUL IN THE STUDY OF MECHANISMS OF VIRAL REPLICATION
    6. SECTION V. ANTNIRAL AGENTS: PAST, PRESENT, AND FUTURE
    7. SECTION VI. AGENTS USEFUL IN THE STUDY OF PATHOGENESIS OF VIRAL DISEASES
    8. SECTION VII. NEWER ANTNIRAL AGENTS
    1. VIRAL SYNTHETASE INHIBITORS AS ANTIVIRAL AGENTS (pages 412–418)

      Alvin J. Glasky, William R. Roderick and J. C. Holper

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12577.x

    2. STUDIES ON THE ANTIVIRAL ACTIVITY OF AMANTADINE HYDROCHLORIDE (pages 432–439)

      Kenneth W. Cochran, Hunein F. Maassab, Akira Tsunoda and Byron S. Berlin

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12579.x

    3. BIOLOGICAL EVALUATION OF ANTIVIRAL A10598 (pages 440–448)

      D. C. DeLong, W. S. Boniece, J. C. Cline and I. S. Johnson

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12580.x

    4. “CYCLOPIN” (pages 449–459)

      Kiarash Naficy

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12581.x

    5. VIRUS INHIBITORY ACTIVITY OF BIGUANIDES AND RELATED COMPOUNDS (pages 460–468)

      Nakao Ishida

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12582.x

    6. ANTIVIRAL ACTIVITY OF SOME PTERIDINES IN ANIMALS (pages 469–473)

      C. Paul Hegarty, Raymond Fagan and Thomas S. Osdene

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12583.x

    7. ANTIVIRAL ACTIVITIES OF EXTRACTS OF THE LEMON BALM PLANT (pages 474–482)

      Louis S. Kucera, Ronald A. Cohen and Ernest C. Herrmann Jr.

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1965.tb12584.x

SEARCH

SEARCH BY CITATION